Technical Data

165618
Grade
Highly Purified
Molecular Formula
C9H6D8N4O3
Molecular Weight
234.28
EU Commodity Code
38220090
Shipping Temp
RT
Storage Temp
RT/4°C
Nimorazole-d8
4-[2-(5-Nitro-1H-imidazol-1-yl)ethyl]morpholine-d8; 1-(β-Morpholinoethyl)-5-nitroimidazole-d8; 4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine-d8; Acterol-d8; Esclama-d8; K-1900-d8; NSC 107524-d8; Naxofem-d8; Naxogin-d8; Nimorazol-d8; Nitrimidazine-d8; Nulogyl-d8
Alternate Name
4-[2-(5-Nitro-1H-imidazol-1-yl)ethyl]morpholine-d8; 1-(β-Morpholinoethyl)-5-nitroimidazole-d8; 4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine-d8; Acterol-d8; Esclama-d8; K-1900-d8; NSC 107524-d8; Naxofem-d8; Naxogin-d8; Nimorazol-d8; Nitrimidazine-d8; Nulogyl-d8
Molecular Formula
C9H6D8N4O3
Molecular Weight
234.28

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

References
Ratnaparkhi, M.P., et al.: Res. J. Pharma. BIol. Chem. Sci., 3, 303 (2012); Toustrup, K., et al.: Radiotherap. Oncol., 102, 122 (2012);
USBio References
No references available
United States Biological | 4 Technology Way | Salem, MA 01970
Phone 800-520-3011 | Fax 978-594-8052 | Website www.usbio.net